Abstract
Paclitaxel (Taxol), an anti-cancer drug derived from Taxus species, was tested for its anti-migrational, anti-invasive and anti-proliferative effect on two human glioma cell lines (GaMg and D-54Mg) grown as multicellular tumour spheroids. In addition, the direct effect of paclitaxel on glioma cells was studied using flow cytometry and scanning confocal microscopy. Both cell lines showed a dose-dependent growth and migratory response to paclitaxel. The GaMg cells were found to be 5-10 times more sensitive to paclitaxel than D-54Mg cells. Paclitaxel also proved to be remarkably effective in preventing invasion in a co-culture system in which tumour spheroids were confronted with fetal rat brain cell aggregates. Control experiments with Cremophor EL (the solvent of paclitaxel for clinical use) in this study showed no effect on tumour cell migration, cell proliferation or cell invasion. Scanning confocal microscopy of both cell lines showed an extensive random organization of the microtubules in the cytoplasm. After paclitaxel exposure, the GaMg and the D-54Mg cells exhibited a fragmentation of the nuclear material, indicating a possible induction of apoptosis. In line with this, flow cytometric DNA histograms showed an accumulation of cells in the G2/M phase of the cell cycle after 24 h of paclitaxel exposure. After 48 h, a deterioration of the DNA histograms was observed indicating nuclear fragmentation.
Full text
PDF








Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Akslen L. A., Andersen K. J., Bjerkvig R. Characteristics of human and rat glioma cells grown in a defined medium. Anticancer Res. 1988 Jul-Aug;8(4):797–803. [PubMed] [Google Scholar]
- Berkova N., Pagé M. Addition of hTNF alpha potentiates cytotoxicity of taxol in human ovarian cancer lines. Anticancer Res. 1995 May-Jun;15(3):863–866. [PubMed] [Google Scholar]
- Bigner D. D., Bigner S. H., Pontén J., Westermark B., Mahaley M. S., Ruoslahti E., Herschman H., Eng L. F., Wikstrand C. J. Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol. 1981 May;40(3):201–229. doi: 10.1097/00005072-198105000-00001. [DOI] [PubMed] [Google Scholar]
- Bjerkvig R., Laerum O. D., Mella O. Glioma cell interactions with fetal rat brain aggregates in vitro and with brain tissue in vivo. Cancer Res. 1986 Aug;46(8):4071–4079. [PubMed] [Google Scholar]
- Bjerkvig R. Reaggregation of fetal rat brain cells in a stationary culture system. II: Ultrastructural characterization. In Vitro Cell Dev Biol. 1986 Apr;22(4):193–200. doi: 10.1007/BF02623303. [DOI] [PubMed] [Google Scholar]
- Bjerkvig R., Steinsvåg S. K., Laerum O. D. Reaggregation of fetal rat brain cells in a stationary culture system. I: Methodology and cell identification. In Vitro Cell Dev Biol. 1986 Apr;22(4):180–192. doi: 10.1007/BF02623302. [DOI] [PubMed] [Google Scholar]
- Cahan M. A., Walter K. A., Colvin O. M., Brem H. Cytotoxicity of taxol in vitro against human and rat malignant brain tumors. Cancer Chemother Pharmacol. 1994;33(5):441–444. doi: 10.1007/BF00686276. [DOI] [PubMed] [Google Scholar]
- Carlsson J., Nilsson K., Westermark B., Pontén J., Sundström C., Larsson E., Bergh J., Påhlman S., Busch C., Collins V. P. Formation and growth of multicellular spheroids of human origin. Int J Cancer. 1983 May 15;31(5):523–533. doi: 10.1002/ijc.2910310502. [DOI] [PubMed] [Google Scholar]
- Chang A. Y., Kim K., Glick J., Anderson T., Karp D., Johnson D. Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results. J Natl Cancer Inst. 1993 Mar 3;85(5):388–394. doi: 10.1093/jnci/85.5.388. [DOI] [PubMed] [Google Scholar]
- Chang C. H., Horton J., Schoenfeld D., Salazer O., Perez-Tamayo R., Kramer S., Weinstein A., Nelson J. S., Tsukada Y. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer. 1983 Sep 15;52(6):997–1007. doi: 10.1002/1097-0142(19830915)52:6<997::aid-cncr2820520612>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
- Chang Y. F., Li L. L., Wu C. W., Liu T. Y., Lui W. Y., P'eng F. K., Chi C. W. Paclitaxel-induced apoptosis in human gastric carcinoma cell lines. Cancer. 1996 Jan 1;77(1):14–18. doi: 10.1002/(SICI)1097-0142(19960101)77:1<14::AID-CNCR4>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
- Crossin K. L., Carney D. H. Microtubule stabilization by taxol inhibits initiation of DNA synthesis by thrombin and by epidermal growth factor. Cell. 1981 Dec;27(2 Pt 1):341–350. doi: 10.1016/0092-8674(81)90417-7. [DOI] [PubMed] [Google Scholar]
- Dugina V. B., Alexandrova A. Y., Lane K., Bulanova E., Vasiliev J. M. The role of the microtubular system in the cell response to HGF/SF. J Cell Sci. 1995 Apr;108(Pt 4):1659–1667. doi: 10.1242/jcs.108.4.1659. [DOI] [PubMed] [Google Scholar]
- Gangemi R. M., Tiso M., Marchetti C., Severi A. B., Fabbi M. Taxol cytotoxicity on human leukemia cell lines is a function of their susceptibility to programmed cell death. Cancer Chemother Pharmacol. 1995;36(5):385–392. doi: 10.1007/BF00686187. [DOI] [PubMed] [Google Scholar]
- Glantz M. J., Choy H., Kearns C. M., Mills P. C., Wahlberg L. U., Zuhowski E. G., Calabresi P., Egorin M. J. Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors. J Natl Cancer Inst. 1995 Jul 19;87(14):1077–1081. doi: 10.1093/jnci/87.14.1077. [DOI] [PubMed] [Google Scholar]
- Gundersen H. J., Jensen E. B. The efficiency of systematic sampling in stereology and its prediction. J Microsc. 1987 Sep;147(Pt 3):229–263. doi: 10.1111/j.1365-2818.1987.tb02837.x. [DOI] [PubMed] [Google Scholar]
- Heimans J. J., Vermorken J. B., Wolbers J. G., Eeltink C. M., Meijer O. W., Taphoorn M. J., Beijnen J. H. Paclitaxel (Taxol) concentrations in brain tumor tissue. Ann Oncol. 1994 Dec;5(10):951–953. doi: 10.1093/oxfordjournals.annonc.a058736. [DOI] [PubMed] [Google Scholar]
- Helson L., Helson C., Malik S., Ainsworth S., Mangiardi J. A saturation threshold for taxol cytotoxicity in human glial and neuroblastoma cells. Anticancer Drugs. 1993 Aug;4(4):487–490. doi: 10.1097/00001813-199308000-00010. [DOI] [PubMed] [Google Scholar]
- Hruban R. H., Yardley J. H., Donehower R. C., Boitnott J. K. Taxol toxicity. Epithelial necrosis in the gastrointestinal tract associated with polymerized microtubule accumulation and mitotic arrest. Cancer. 1989 May 15;63(10):1944–1950. doi: 10.1002/1097-0142(19890515)63:10<1944::aid-cncr2820631013>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
- Jordan M. A., Toso R. J., Thrower D., Wilson L. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9552–9556. doi: 10.1073/pnas.90.20.9552. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liebmann J. E., Cook J. A., Lipschultz C., Teague D., Fisher J., Mitchell J. B. Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines. Br J Cancer. 1993 Dec;68(6):1104–1109. doi: 10.1038/bjc.1993.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lund-Johansen M., Engebraaten O., Bjerkvig R., Laerum O. D. Invasive glioma cells in tissue culture. Anticancer Res. 1990 Sep-Oct;10(5A):1135–1151. [PubMed] [Google Scholar]
- McGuire W. P., Rowinsky E. K., Rosenshein N. B., Grumbine F. C., Ettinger D. S., Armstrong D. K., Donehower R. C. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med. 1989 Aug 15;111(4):273–279. doi: 10.7326/0003-4819-111-4-273. [DOI] [PubMed] [Google Scholar]
- Mueller-Klieser W. Multicellular spheroids. A review on cellular aggregates in cancer research. J Cancer Res Clin Oncol. 1987;113(2):101–122. doi: 10.1007/BF00391431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nygren P., Csoka K., Jonsson B., Fridborg H., Bergh J., Hagberg H., Glimelius B., Brodin O., Tholander B., Kreuger A. The cytotoxic activity of Taxol in primary cultures of tumour cells from patients is partly mediated by Cremophor EL. Br J Cancer. 1995 Mar;71(3):478–481. doi: 10.1038/bjc.1995.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Otto A. M., Jimenez de Asua L. Microtubule-disrupting agents can independently affect the prereplicative period and the entry into S phase stimulated by prostaglandin F2 alpha and fibroblastic growth factor. J Cell Physiol. 1983 Apr;115(1):15–22. doi: 10.1002/jcp.1041150104. [DOI] [PubMed] [Google Scholar]
- Riondel J., Jacrot M., Fessi H., Puisieux F., Potier Effects of free and liposome-encapsulated taxol on two brain tumors xenografted into nude mice. In Vivo. 1992 Jan-Feb;6(1):23–27. [PubMed] [Google Scholar]
- Rowinsky E. K., Cazenave L. A., Donehower R. C. Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst. 1990 Aug 1;82(15):1247–1259. doi: 10.1093/jnci/82.15.1247. [DOI] [PubMed] [Google Scholar]
- Schiff P. B., Fant J., Horwitz S. B. Promotion of microtubule assembly in vitro by taxol. Nature. 1979 Feb 22;277(5698):665–667. doi: 10.1038/277665a0. [DOI] [PubMed] [Google Scholar]
- Schiff P. B., Horwitz S. B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1561–1565. doi: 10.1073/pnas.77.3.1561. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Silbergeld D. L., Chicoine M. R., Madsen C. L. In vitro assessment of Taxol for human glioblastoma: chemosensitivity and cellular locomotion. Anticancer Drugs. 1995 Apr;6(2):270–276. doi: 10.1097/00001813-199504000-00011. [DOI] [PubMed] [Google Scholar]
- Sollott S. J., Cheng L., Pauly R. R., Jenkins G. M., Monticone R. E., Kuzuya M., Froehlich J. P., Crow M. T., Lakatta E. G., Rowinsky E. K. Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J Clin Invest. 1995 Apr;95(4):1869–1876. doi: 10.1172/JCI117867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stearns M. E., Wang M. Taxol blocks processes essential for prostate tumor cell (PC-3 ML) invasion and metastases. Cancer Res. 1992 Jul 1;52(13):3776–3781. [PubMed] [Google Scholar]
- Storme G., Mareel M., De Bruyne G. Influence of cells number on directional migration of MO4 cells in vitro. Arch Geschwulstforsch. 1981;51(1):45–50. [PubMed] [Google Scholar]
- Stracke M. L., Soroush M., Liotta L. A., Schiffmann E. Cytoskeletal agents inhibit motility and adherence of human tumor cells. Kidney Int. 1993 Jan;43(1):151–157. doi: 10.1038/ki.1993.25. [DOI] [PubMed] [Google Scholar]
- Sutherland R. M. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science. 1988 Apr 8;240(4849):177–184. doi: 10.1126/science.2451290. [DOI] [PubMed] [Google Scholar]
- Sutherland R., Freyer J., Mueller-Klieser W., Wilson R., Heacock C., Sciandra J., Sordat B. Cellular growth and metabolic adaptations to nutrient stress environments in tumor microregions. Int J Radiat Oncol Biol Phys. 1986 Apr;12(4):611–615. doi: 10.1016/0360-3016(86)90070-2. [DOI] [PubMed] [Google Scholar]
- Teng M. H., Bartholomew J. C., Bissell M. J. Synergism between anti-microtubule agents and growth stimulants in enhancement of cell cycle traverse. Nature. 1977 Aug 25;268(5622):739–741. doi: 10.1038/268739a0. [DOI] [PubMed] [Google Scholar]
- Tishler R. B., Schiff P. B., Geard C. R., Hall E. J. Taxol: a novel radiation sensitizer. Int J Radiat Oncol Biol Phys. 1992;22(3):613–617. doi: 10.1016/0360-3016(92)90888-o. [DOI] [PubMed] [Google Scholar]
- Trapp B. D., Webster H. D., Johnson D., Quarles R. H., Cohen S. R., Murray M. R. Myelin formation in rotation-mediated aggregating cell cultures: immunocytochemical, electron microscopic, and biochemical observations. J Neurosci. 1982 Jul;2(7):986–993. doi: 10.1523/JNEUROSCI.02-07-00986.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Verschueren H., Dewit J., De Braekeleer J., Schirrmacher V., De Baetselier P. Motility and invasive potency of murine T-lymphoma cells: effect of microtubule inhibitors. Cell Biol Int. 1994 Jan;18(1):11–19. doi: 10.1006/cbir.1994.1002. [DOI] [PubMed] [Google Scholar]
- Wahl A. F., Donaldson K. L., Fairchild C., Lee F. Y., Foster S. A., Demers G. W., Galloway D. A. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nat Med. 1996 Jan;2(1):72–79. doi: 10.1038/nm0196-72. [DOI] [PubMed] [Google Scholar]
- Walter K. A., Cahan M. A., Gur A., Tyler B., Hilton J., Colvin O. M., Burger P. C., Domb A., Brem H. Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. Cancer Res. 1994 Apr 15;54(8):2207–2212. [PubMed] [Google Scholar]
- Wani M. C., Taylor H. L., Wall M. E., Coggon P., McPhail A. T. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc. 1971 May 5;93(9):2325–2327. doi: 10.1021/ja00738a045. [DOI] [PubMed] [Google Scholar]
- Yuhas J. M., Li A. P., Martinez A. O., Ladman A. J. A simplified method for production and growth of multicellular tumor spheroids. Cancer Res. 1977 Oct;37(10):3639–3643. [PubMed] [Google Scholar]


